The largest database of trusted experimental protocols

Mir 590 5p inhibitor

Manufactured by GenePharma
Sourced in China

The MiR-590-5p inhibitor is a laboratory reagent designed to inhibit the expression of the microRNA miR-590-5p. This inhibitor can be used in research applications to study the biological functions and regulatory roles of miR-590-5p in various cell and tissue systems.

Automatically generated - may contain errors

4 protocols using mir 590 5p inhibitor

1

Transfection and Gene Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following 24 h of incubation at 37°C with 5% CO2, NCI-H23 cells in the logarithmic growth phase were transfected with 500 pmol control small interfering RNA (siRNA) (cat. no. siN0000001-1-5; Ribobio), 500 pmol NUTM2A-AS1-siRNA (cat. no. siB180131045110-1-5; Ribobio), 50 nM inhibitor control (5′-GUCCAGUGAAUUCCCAG-3′; Shanghai GenePharma Co., Ltd.), 50 nM miR-590-5p inhibitor (5′-AAAUAUGCUGUAUGUCAUGUGUU-3′; Shanghai GenePharma Co., Ltd.), 100 nM mimic control (5′-CGCCAAUAUCAUUAUACCUC-3′; Shanghai GenePharma Co., Ltd.), 100 nM miR-590-5p mimic (5′-GAGCUUAUUCAUAAAAUGCAG−3′; Shanghai GenePharma Co., Ltd.), 1 µg control-plasmid (sc-437275; Santa Cruz), 1 µg METTL3-plasmid (sc-404029-ACT; Santa Cruz Biotechnology, Inc.), 500 pmol NUTM2A-AS1-siRNA + 50 nM inhibitor control, 500 pmol NUTM2A-AS1-siRNA + 50 nM miR-590-5p inhibitor, 100 nM miR-590-5p mimic + 1 µg control-plasmid or 100 nM miR-590-5p mimic + 1 µg METTL3-plasmid using Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) at 37°C for 48 h. 48 h after transfection, the transfection efficiencies were assessed using reverse transcription-quantitative PCR (RT-qPCR), and subsequent experiments were performed.
+ Open protocol
+ Expand
2

Investigating miR-590-5p and RECK Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-590-5p mimics, mimic control, miR-590-5p inhibitor, and inhibitor control were synthesized by GenePharma (Shanghai, People’s Republic of China). For cell transfection, cells were seeded in six-well plates (2×105/well), and transfection was performed using Lipofectamine 2000 (Thermo Fisher Scientific). For luciferase activity analysis, the 3′-UTR of RECK containing the putative binding sites for miR-590-5p was amplified and cloned into the pGL3-luciferase reporter plasmid (Promega Corporation, Madison, WI, USA). Mutations in the miR-590-5p binding sites of RECK 3′-UTR were generated using a QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA). For stably overexpressing miR-590-5p cells, the lentiviruses expressing miR-590-5p and control viruses were used to infect SGC-7901 cells.
The siRNA 5′-AAGACCCAGCCCUUGCCUCAA-3′ (sense) was used to knock down the expression of RECK, and the RNA 5′-AACGUUGCGAUAGCGUAGUAC-3′ was used as a control. The RECK coding region with and without the 3′-UTR was obtained from Hanbio (Shanghai, People’s Republic of China).
+ Open protocol
+ Expand
3

Modulating colorectal cancer metastasis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CRC cell lines SW480, SW620, HT29, HCT116, and Lovo and normal human colonic epithelial cells NCM460 were cultivated in DMEM medium (Gibco, NY, USA) supplemented with 10% FBS (Gibco). The cells were then incubated in a humidified atmosphere. Subsequently, SW480 and Lovo cells were transfected with 50 nM of miR-590-5p inhibitor (Shanghai GenePharma Co., Ltd.), small interfering RNA (si) against circ-PITHD1 (si-circ-PITHD1, 5′-CGCUCCAAGUUUGUUGAAAUU-3′ (Shanghai GenePharma Co., Ltd.)), and the HK2 overexpression vector (HK2, HK2 cDNA sequence clone into pcDNA3.1 vector (Shanghai GenePharma Co., Ltd.)) via Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). SW480 and Lovo cells were collected 2 days after transfection. To better verify the circ-PITHD effects during the experiments, lentiviral-based small hairpin RNA (shRNA) targeting circ-PITHD1 was performed. The GFP process was made 3 d after infection into SW480, which had a green fluorescence >95%. For in vivo metastatic detection, pLVX-Luc2-P2A-AcGFP1-puro lentiviral vector (Novagen) was utilized for SW480 infection, which produced the luc-SW480 cell line.
+ Open protocol
+ Expand
4

Linc-USP16 and miRNA Regulation in Cellular Processes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Linc-USP16 shRNA and miR-21, miR-21 inhibitor, miR-590-5p, and miR-590-5p inhibitor were purchased from GenePharma (Shanghai, China). The lentiviral transduction particles for shRNA-mediated knockdown of PTEN were purchased from Sigma (Shanghai, China). The shRNA sequence targeting PTEN was 5'-GCGCTATGTGTATTATTAT-3'. The shRNA was cloned using the PLKO.1 vector. Stable knockdown cells were established as previously described [13] [14] [15] .
Human Linc-USP16 cDNA was inserted into the pCDH vector using the following primers: F: 5-TAATAACATCTACCAAACAG-3 and R: 5-ACTGGGTCAGAGAATACA-3. Stable Linc-USP16-overexpressing cells were generated as previously described [16, 17] .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!